Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129244) titled 'Pathway construction and effectiveness evaluation of AI-enhanced influenza... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129252) titled 'Impact of Adherence to Artificial Liver Support System Treatment on Outcom... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (SLCTR/2026/019) titled 'Effectiveness and Safety of Intravenous followed by Intranasal Racemic Ketam... Read More
Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (TCTR20260801002) titled 'Subacromial Injection of Tranexamic Acid Combined with Ropivacaine Versus R... Read More
Singapore, July 31 -- The Health Sciences Authority received information related to the study titled 'A Multicenter, Multi-Part, Phase 1/2 Study of EIK1005 as Monotherapy and in Combination with Pembr... Read More
Singapore, July 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-controlled, Multicenter, Parallel-group Study to Eval... Read More
Singapore, July 31 -- The Health Sciences Authority received information related to the study titled 'Responses Against Paramyxoviruses in T cells with crOss Reactivity'. The following are the other r... Read More
Singapore, July 31 -- The Health Sciences Authority received information related to the study titled 'Effect of innate immune reprogramming by primary dengue on host response to secondary dengue'. The... Read More
Singapore, July 31 -- The Health Sciences Authority received information related to the study titled 'Validation of Gore Test in patients with Sphincteric Dyssynergia presenting with Dysfunctional Voi... Read More
Singapore, July 31 -- The Health Sciences Authority received information related to the study titled 'An open-label, randomized, controlled phase 3 study of enfortumab vedotin in combination with pemb... Read More